Clinical trial
The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell…
NCT00207805 · Centre National de Greffe de Moelle Osseuse, Other · Completed
Key facts
| NCT number | NCT00207805 |
|---|---|
| Title | The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma |
| Lead sponsor | Centre National de Greffe de Moelle Osseuse, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Procedure |
| Interventions | autologous PBSC transplant |
| Enrollment | 202 |
| Start date | May 1, 2003 |
| First posted | Sep 21, 2005 |
| Last update posted | Jan 27, 2009 |
| Countries | Tunisia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: